10-Q Filing

Processa Pharmaceuticals, Inc. CIK: 1533743 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0001493152-23-040472`
Period End Date	20230930
Filing Date	20231113
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 63 Income Statement 40 Cash Flow Statement 68 Stockholders Equity 36

Balance Sheet 63 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.50M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	16.14M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.86M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	24.73M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	16.04M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$1.05M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	24.63M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$1.88M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$7.91M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$8.39M	USD	Point-in-time
Treasury stock shares	`TreasuryStockCommonShares`	100,000.00	shares	Point-in-time
Treasury stock shares	`TreasuryStockCommonShares`	100,000.00	shares	Point-in-time
Property and Equipment, net	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Property and Equipment, net	`PropertyPlantAndEquipmentNet`	$2.69K	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$167.03K	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$227.59K	USD	Point-in-time
Security deposit	`SecurityDeposit`	$5.54K	USD	Point-in-time
Security deposit	`SecurityDeposit`	$5.54K	USD	Point-in-time
Total Other Assets	`OtherAssetsNoncurrent`	$172.57K	USD	Point-in-time
Total Other Assets	`OtherAssetsNoncurrent`	$233.12K	USD	Point-in-time
Total Assets	`Assets`	$8.08M	USD	Point-in-time
Total Assets	`Assets`	$8.62M	USD	Point-in-time
Current maturities of operating lease liability	`OperatingLeaseLiabilityCurrent`	$82.74K	USD	Point-in-time
Current maturities of operating lease liability	`OperatingLeaseLiabilityCurrent`	$78.90K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$346.30K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$327.55K	USD	Point-in-time
Due to licensor	`DueToLicensor`	$189.00K	USD	Point-in-time
Due to licensor	`DueToLicensor`	$189.00K	USD	Point-in-time
Due to related parties	`OtherLiabilitiesCurrent`	$5.79K	USD	Point-in-time
Due to related parties	`OtherLiabilitiesCurrent`	$51.00	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$202.24K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$403.06K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$826.07K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$998.56K	USD	Point-in-time
Non-current operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$150.55K	USD	Point-in-time
Non-current operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$88.78K	USD	Point-in-time
Total Liabilities	`Liabilities`	$914.85K	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.15M	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, par value $0.0001, 100,000,000 shares authorized: 24,731,474 issued and 24,631,474 outstanding at September 30, 2023, and 16,135,400 issued and 16,035,400 outstanding at December 31, 2022	`CommonStockValue`	$2.47K	USD	Point-in-time
Common stock, par value $0.0001, 100,000,000 shares authorized: 24,731,474 issued and 24,631,474 outstanding at September 30, 2023, and 16,135,400 issued and 16,035,400 outstanding at December 31, 2022	`CommonStockValue`	$1.61K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$72.02M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$80.43M	USD	Point-in-time
Treasury stock at cost 100,000 shares at September 30, 2023 and December 31, 2022	`TreasuryStockValue`	$300.00K	USD	Point-in-time
Treasury stock at cost 100,000 shares at September 30, 2023 and December 31, 2022	`TreasuryStockValue`	$300.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-64.25M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-72.96M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$25.49M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$10.14M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$20.08M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$9.16M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$7.47M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$17.24M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$7.17M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$23.24M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$8.62M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$8.08M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$4.48M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$3.14M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$8.32M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.15M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.51M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$6.14M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.92M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.02M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-14.46M	USD	3 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-2.17M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-6.06M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-8.99M	USD	3 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$45.67K	USD	3 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$271.02K	USD	3 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$85.66K	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$36.71K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-14.41M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-2.61M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-5.16M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-4.02M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-8.72M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-3.23M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-2.08M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-6.02M	USD	1 Quarter
Net Loss per Common Share - Basic	`EarningsPerShareBasic`	$-0.08	USD	1 Quarter
Net Loss per Common Share - Basic	`EarningsPerShareBasic`	$-0.34	USD	3 Qtrs
Net Loss per Common Share - Basic	`EarningsPerShareBasic`	$-0.90	USD	3 Qtrs
Net Loss per Common Share - Basic	`EarningsPerShareBasic`	$-0.37	USD	1 Quarter
Net Loss per Common Share - Diluted	`EarningsPerShareDiluted`	$-0.90	USD	3 Qtrs
Net Loss per Common Share - Diluted	`EarningsPerShareDiluted`	$-0.37	USD	1 Quarter
Net Loss per Common Share - Diluted	`EarningsPerShareDiluted`	$-0.34	USD	3 Qtrs
Net Loss per Common Share - Diluted	`EarningsPerShareDiluted`	$-0.08	USD	1 Quarter
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	25.59M	shares	3 Qtrs
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	27.00M	shares	1 Quarter
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	16.20M	shares	1 Quarter
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	15.99M	shares	3 Qtrs
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	27.00M	shares	1 Quarter
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	15.99M	shares	3 Qtrs
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	25.59M	shares	3 Qtrs
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	16.20M	shares	1 Quarter

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-14.41M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.61M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.16M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.72M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.23M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.02M	USD	1 Quarter
Depreciation	`Depreciation`	-	USD	3 Qtrs
Depreciation	`Depreciation`	$82.00	USD	3 Qtrs
Lease expense for right-of-use assets	`OperatingLeaseExpense`	$66.13K	USD	3 Qtrs
Lease expense for right-of-use assets	`OperatingLeaseExpense`	$60.55K	USD	3 Qtrs
Milestone expense in connection with license agreement	`OtherNoncashIncomeExpense`	-	USD	3 Qtrs
Milestone expense in connection with license agreement	`OtherNoncashIncomeExpense`	$-189.00K	USD	3 Qtrs
Amortization of issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	-	USD	3 Qtrs
Amortization of issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$78.11K	USD	3 Qtrs
Amortization of intangible asset	`AmortizationOfIntangibleAssets`	-	USD	3 Qtrs
Amortization of intangible asset	`AmortizationOfIntangibleAssets`	$591.37K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$6.05M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$3.21M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$142.89K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$803.52K	USD	3 Qtrs
Warrants issued to purchase 3,160,130 shares of common stock in connection with a consulting agreement	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$1.31M	USD	3 Qtrs
Warrants issued to purchase 3,160,130 shares of common stock in connection with a consulting agreement	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	3 Qtrs
Prepaid expenses and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-836.34K	USD	3 Qtrs
Prepaid expenses and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-299.07K	USD	3 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-57.93K	USD	3 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-69.42K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$92.16K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$18.75K	USD	3 Qtrs
Due (from) to related parties	`IncreaseDecreaseInDueToRelatedParties`	$-1.77K	USD	3 Qtrs
Due (from) to related parties	`IncreaseDecreaseInDueToRelatedParties`	$5.74K	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-70.27K	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-200.82K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-62.86K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.11M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.94M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.78K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.78K	USD	3 Qtrs
Net proceeds from common stock issued	`ProceedsFromIssuanceOfCommonStock`	$-35.25K	USD	3 Qtrs
Net proceeds from common stock issued	`ProceedsFromIssuanceOfCommonStock`	$6.35M	USD	3 Qtrs
Settlement of stock award	`PaymentsForSettlementOfStockAwards`	-	USD	3 Qtrs
Settlement of stock award	`PaymentsForSettlementOfStockAwards`	$52.75K	USD	3 Qtrs
Acquisition of treasury stock	`PaymentsForRepurchaseOfEquity`	$300.00K	USD	3 Qtrs
Acquisition of treasury stock	`PaymentsForRepurchaseOfEquity`	-	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-335.25K	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.30M	USD	3 Qtrs
Net Increase (Decrease) in Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-7.44M	USD	3 Qtrs
Net Increase (Decrease) in Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$357.08K	USD	3 Qtrs
Cash and Cash Equivalents Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$9.05M	USD	Point-in-time
Cash and Cash Equivalents Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$6.50M	USD	Point-in-time
Cash and Cash Equivalents Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$6.86M	USD	Point-in-time
Cash and Cash Equivalents Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$16.50M	USD	Point-in-time
Cash and Cash Equivalents End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$9.05M	USD	Point-in-time
Cash and Cash Equivalents End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$6.50M	USD	Point-in-time
Cash and Cash Equivalents End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$6.86M	USD	Point-in-time
Cash and Cash Equivalents End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$16.50M	USD	Point-in-time
Issuance of 123,609 shares of common stock in connection with the Purchase Agreement with Lincoln Park	`StockIssued1`	-	USD	3 Qtrs
Issuance of 123,609 shares of common stock in connection with the Purchase Agreement with Lincoln Park	`StockIssued1`	$450.00K	USD	3 Qtrs
Right-of-use asset obtained in exchange for operating lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$238.92K	USD	3 Qtrs
Right-of-use asset obtained in exchange for operating lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	3 Qtrs
Operating lease liability	`OperatingLeaseLiabilities`	-	USD	3 Qtrs
Operating lease liability	`OperatingLeaseLiabilities`	$238.92K	USD	3 Qtrs
Net	`NonCashleaseLiabilityNet`	-	USD	3 Qtrs
Net	`NonCashleaseLiabilityNet`	-	USD	3 Qtrs

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$25.49M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$20.08M	USD	Point-in-time
Balance	`StockholdersEquity`	$9.16M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$17.24M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.17M	USD	Point-in-time
Balance	`StockholdersEquity`	$23.24M	USD	Point-in-time
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.21M	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$319.12K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$2.01M	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$341.50K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$828.90K	USD	1 Quarter
Acquisition of treasury stock	`StockRepurchasedDuringPeriodValue`	$300.00K	USD	1 Quarter
Shares issued in connection with purchase agreement	`SharesIssuedInConnectionWithPurchaseAgreementValue`	$450.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-14.41M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.61M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.16M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.72M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.23M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.02M	USD	1 Quarter
Shares withheld to pay income taxes on stock-based compensation	`SharesWithheldToPayIncomeTaxOnStockbasedCompensation`	$35.25K	USD	1 Quarter
Shares issued in connection with capital raises, net of transaction costs	`StockIssuedDuringPeriodValueNewIssues`	$6.35M	USD	1 Quarter
Warrant granted in connection with a consulting agreement	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$1.31M	USD	1 Quarter
Stock-based compensation, net of forfeitures	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$142.89K	USD	1 Quarter
Settlement of stock award	`AdjustmentsToAdditionalPaidInCapitalSettlementOfStockAwards`	$52.75K	USD	1 Quarter
Balance	`StockholdersEquity`	$25.49M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$20.08M	USD	Point-in-time
Balance	`StockholdersEquity`	$9.16M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$17.24M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.17M	USD	Point-in-time
Balance	`StockholdersEquity`	$23.24M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.